Applied Therapeutics Inc
NASDAQ:APLT

Watchlist Manager
Applied Therapeutics Inc Logo
Applied Therapeutics Inc
NASDAQ:APLT
Watchlist
Price: 10.09 USD 3.59% Market Closed
Market Cap: 1.2B USD
Have any thoughts about
Applied Therapeutics Inc?
Write Note

Relative Value

The Relative Value of one APLT stock under the Base Case scenario is 7.16 USD. Compared to the current market price of 10.09 USD, Applied Therapeutics Inc is Overvalued by 29%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

APLT Relative Value
Base Case
7.16 USD
Overvaluation 29%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
0
vs Industry
20
Median 3Y
5.9
Median 5Y
0
Industry
8.1
Forward
630.8
vs History
vs Industry
Median 3Y
-1.5
Median 5Y
-2.7
Industry
23
Forward
-10.4
vs History
vs Industry
Median 3Y
-1.8
Median 5Y
-5.4
Industry
23.4
vs History
vs Industry
Median 3Y
-1.7
Median 5Y
-5.3
Industry
27.3
vs History
4
vs Industry
9
Median 3Y
2.6
Median 5Y
4.4
Industry
2.6
vs History
0
vs Industry
20
Median 3Y
3.7
Median 5Y
0
Industry
8.1
Forward
564.2
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.6
vs History
vs Industry
Median 3Y
-1.1
Median 5Y
-3.1
Industry
4.3
Forward
-12.9
vs History
vs Industry
Median 3Y
-1.1
Median 5Y
-3.1
Industry
3.8
Forward
-12
vs History
vs Industry
Median 3Y
-1.2
Median 5Y
-4.1
Industry
6
vs History
vs Industry
Median 3Y
-1.2
Median 5Y
-4.1
Industry
3.8
vs History
12
vs Industry
0
Median 3Y
42.5
Median 5Y
65.2
Industry
4.8

Multiples Across Competitors

APLT Competitors Multiples
Applied Therapeutics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Applied Therapeutics Inc
NASDAQ:APLT
1.2B USD 112.2 -4.8 -8.5 -8.5
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 015 917.2 -175 931.2 -213 636.5 -211 198.6
US
Abbvie Inc
NYSE:ABBV
352.5B USD 6.3 69.4 17 26.2
US
Amgen Inc
NASDAQ:AMGN
174.8B USD 5.4 41.3 18.9 35.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
133.2B USD 12.5 -277.5 28.2 29.6
US
Gilead Sciences Inc
NASDAQ:GILD
120.3B USD 4.3 955 10.6 10.6
US
Epizyme Inc
F:EPE
94.1B EUR 1 903.2 -485.6 -528.9 -514.8
AU
CSL Ltd
ASX:CSL
137.9B AUD 6.1 34.4 21.1 26.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
91.2B USD 6.6 19.6 18 20.1
US
Seagen Inc
F:SGT
39.3B EUR 18.3 -56.2 -60.4 -54.5
NL
argenx SE
XBRU:ARGX
33.2B EUR 18.3 -128.3 -103.1 -75.1
P/E Multiple
Earnings Growth
US
Applied Therapeutics Inc
NASDAQ:APLT
Average P/E: 223.9
Negative Multiple: -4.8
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -175 931.2 N/A
US
Abbvie Inc
NYSE:ABBV
69.4
412%
US
Amgen Inc
NASDAQ:AMGN
41.3
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -277.5
42%
US
Gilead Sciences Inc
NASDAQ:GILD
955
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -485.6 N/A
AU
CSL Ltd
ASX:CSL
34.4
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.6
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -56.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -128.3 N/A
EV/EBITDA Multiple
EBITDA Growth
US
Applied Therapeutics Inc
NASDAQ:APLT
Average EV/EBITDA: 19
Negative Multiple: -8.5
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -213 636.5 N/A
US
Abbvie Inc
NYSE:ABBV
17
28%
US
Amgen Inc
NASDAQ:AMGN
18.9
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28.2
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.6
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -528.9 N/A
AU
CSL Ltd
ASX:CSL
21.1
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -103.1 N/A
EV/EBIT Multiple
EBIT Growth
US
Applied Therapeutics Inc
NASDAQ:APLT
Average EV/EBIT: 24.7
Negative Multiple: -8.5
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -211 198.6 N/A
US
Abbvie Inc
NYSE:ABBV
26.2
88%
US
Amgen Inc
NASDAQ:AMGN
35.7
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
29.6
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.6
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.8 N/A
AU
CSL Ltd
ASX:CSL
26.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
20.1
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.5 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -75.1 N/A

See Also

Discover More
Back to Top